Patents by Inventor Birgit Jordan

Birgit Jordan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7563582
    Abstract: The invention relates to processes for identifying chemical compounds which are capable of modulating the interaction between VASP and zyxin. VASP or a VASP derivative and zyxin or a zyxin derivative which interact with one another are brought into contact with a chemical compound to be examined. The effect on the interaction can be determined using antibodies against VASP or a VASP derivative and/or zyxin or a zyxin derivative, or with the aid of fluorescent labels on VASP or a VASP derivative and zyxin or a zyxin derivative.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: July 21, 2009
    Assignee: sanofi-aventis Deutschland GmbH
    Inventors: Birgit Jordan, Peter Drückes, Thomas Jarchau, Ulrich Walter
  • Publication number: 20020136717
    Abstract: The invention relates to processes for identifying chemical compounds which are capable of modulating the interaction between VASP and zyxin. VASP or a VASP derivative and zyxin or a zyxin derivative which interact with one another are brought into contact with a chemical compound to be examined. The effect on the interaction can be determined using antibodies against VASP or a VASP derivative and/or zyxin or a zyxin derivative, or with the aid of fluorescent labels on VASP or a VASP derivative and zyxin or a zyxin derivative.
    Type: Application
    Filed: November 21, 2001
    Publication date: September 26, 2002
    Inventors: Birgit Jordan, Peter Druckes, Thomas Jarchau, Ulrich Walter
  • Patent number: 6080719
    Abstract: The invention relates to compounds of the formula Icyclo(A-B-C-E-F-(D)-Ala) (I)in which A, B, C, E and F are each independently the residue of a natural amino acid other than cysteine (Cys) and tryptophan (Trp), their mixtures and their physiologically tolerated salts; to a process for their preparation and to their use for preparing a diagnostic agent, a medicament for the treatment or prophylaxis of allergies and infections, or a scientific tool for inhibiting the binding of interleukin-4 (IL-4) to the IL-4 receptor.
    Type: Grant
    Filed: February 23, 1996
    Date of Patent: June 27, 2000
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Stephan Henke, Birgit Jordan, Jochen Knolle, Leander Lauffer, Susanne Feiertag, Karl-Heinz Wiesmuller, Gunther Jung
  • Patent number: 5869447
    Abstract: The invention relates to compounds of the formula Icyclo(A-B-C-E-F-(D)-Ala) (I)in whichA, B, C, E and F are each independently the residue of a natural amino acid other than cysteine (Cys) and tryptophan (Trp), their mixtures and their physiologically tolerated salts; to a process for their preparation and to their use for preparing a diagnostic agent, a medicament for the treatment or prophylaxis of allergies and infections, or a scientific tool for inhibiting the binding of interleukin-4 (IL-4) to the IL-4 receptor.
    Type: Grant
    Filed: December 13, 1995
    Date of Patent: February 9, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Stephan Henke, Birgit Jordan, Jochen Knolle, Leander Lauffer, Susanne Feiertag, Karl-Heinz Wiesmuller, Gunther Jung